McKesson Corp reported higher-than-expected quarterly profit and revenue on growth in both of its divisions, and the pharmaceutical wholesaler raised its full-year earnings forecast.
Excluding items, such as a $118 million charge to increase litigation reserves, McKesson earned $1.63 per share. Analysts on average expected $1.39, according to Thomson Reuters I/B/E/S.
Based on what it said was momentum from its first half results, McKesson boosted its earnings forecast by 10 cents and now expects to earn $6.19 to $6.39 per share for the fiscal year ending March 31, 2012.
The San Francisco-based company posted a net profit of $296 million, or $1.18 per share, for its fiscal second quarter ended Sept. 30, compared with a profit of $327 million, or $1.25 per share, a year ago.
Revenue for the quarter rose 10 percent to $30.22 billion, topping Wall Street estimates of $29.48 billion.
© 2026 Thomson/Reuters. All rights reserved.